Clinical Effectiveness of Tislelizumab With Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as Adjuvant Therapy for High‐Risk Muscle‐Invasive Urothelial Carcinoma: A Real‐World Study.
Saved in:
| Title: | Clinical Effectiveness of Tislelizumab With Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as Adjuvant Therapy for High‐Risk Muscle‐Invasive Urothelial Carcinoma: A Real‐World Study. |
|---|---|
| Authors: | Wang, Yanjun1 (AUTHOR), Zhong, Kaihua2 (AUTHOR), Tan, Xingliang1 (AUTHOR), Zhou, Qianghua1 (AUTHOR), Jiang, Lijuan1 (AUTHOR), Yao, Kai1 (AUTHOR) yaokai@sysucc.org.cn, Wu, Zhiming1 (AUTHOR) wuzhim@sysucc.org.cn |
| Source: | Cancer Medicine. Feb2025, Vol. 14 Issue 4, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.70661 |
